+91-8668442535

Hearing Screening And Diagnostic Devices Market By Test (Pure Tone Test, Tympanometry Test, Speech Reception Threshold Test, Most Comfortable Listening Level Test, Uncomfortable Loudness Level Test, Speech Discrimination Test, Bone Conduction Test and Others), By Indications (Conductive Hearing Loss, Sensorineural Hearing Loss, Combination Hearing Loss and Others) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Hearing disability is considered if the hearing loss is more than 40 dB in adults and 30 dB in children in the age group of 0–14 years. According to the World Health Organization's 2015 report, the number of people suffering from hearing loss is 360 million, which represents 5.3% of the world's population. Low-frequency sounds are sensed near the apex of the cochlea, and high-frequency sounds are sensed near the base. A precise understanding of the ear anatomy is important to perform an effective diagnosis and determine the probable cause of hearing loss.

The test types included in the scope of the report are the speech discrimination test, the pure tone test, the tympanometry test, the speech reception threshold test, the most comfortable listening level test, the bone conduction test, the uncomfortable loudness level test, and others. By all indications, the hearing screening and diagnostic devices are sub-segmented as conductive hearing loss, sensorineural hearing loss, combination hearing loss, and others.

Market sizing and forecasting furnish information regarding the performance of various tests and indications in different geographical regions.

The competitive landscape may explain the current competition in hearing screening and diagnostic devices. The competitive landscape is mapped using parameters such as geographic coverage, product portfolio, and inception. The diverse range of products available on the market for diagnosis and evaluation purposes is covered in the company profiles. Porter's five forces analysis gives a brief description of the business analytics of hearing screening and diagnostic devices. The outstanding manufacturers actively engaged in the production of hearing screening and diagnostic devices are Accent Hearing Pty. Ltd., GN Otometrics, Interacoustics A/S, IntriCon Corporation, MAICO Diagnostics GmbH, Nashua Hearing Group, Natus Medical Incorporated, Neurosoft, OTODYNAMICS Ltd., and Siemens Healthcare GmbH.

Based on indications, the hearing screening and diagnostic devices market is categorized into:

  • Conductive hearing loss
  • Sensorineural hearing loss
  • Hearing loss in combination
  • Others

According to the research findings of the World Health Organization, loss of hearing is the sixth largest contributor to the global burden of diseases. In today's cultural environment of faster information exchange, it has a severe negative social impact on patients. There is rehabilitative treatment available for any kind of hearing loss, provided a timely and accurate diagnosis is performed. Anatomically, the ear is divided into three sections: the external, middle, and inner ear and the disease etiology for hearing loss involves more than one section of the ear. At present, conductive hearing loss is the most widely diagnosed ear complication, owing to the rising prevalence of patients suffering from cerumen impaction and otosclerosis. In addition, patients suffering from severe otitis media later develop conductive hearing loss. Sensorineural hearing loss is on the rise due to an increase in loud noise exposure, inherited disorders, and presbycusis.

Based on test results, the global hearing screening and diagnostic devices market is categorized into

  • Pure Tone Test
  • Tympanometry Test
  • Speech Reception Threshold Test
  • Most Comfortable Listening Level Test (MCL)
  • Uncomfortable Loudness Level Test (UCL)
  • Speech Discrimination Test
  • Bone Conduction Examination
  • Others

Hearing diagnostic devices assess a person's sensitivity to hear as well as the severity of hearing loss. The facets that contribute to the market growth of hearing screening and diagnostic devices are increasing cases of ear trauma due to medication or toxins and rising noise pollution due to rapid urbanization. Tympanometry tests are widely used by ENT surgeons to perform precise middle ear diagnoses. It is used for the detection of fluid and perforation in the eardrums in otitis media infections. The pure tone test and bone conduction test together are gaining tremendous importance for their ability to evaluate the degree of hearing loss in patients. If the results of both tests are the same, the patient is diagnosed with sensorineural hearing loss; if the results are different, the patient is diagnosed with conductive hearing loss. The chief players that dominate the hearing screening and diagnostic devices market are Accent Hearing Pty. Ltd., GN Otometrics, Interacoustics A/S, IntriCon Corporation, MAICO Diagnostics GmbH, Nashua Hearing Group, Natus Medical Incorporated, Neurosoft, OTODYNAMICS Ltd., and Siemens Healthcare GmbH.

For the purpose of this study, the global market for hearing screening and diagnostic devices is categorized into the following regional and country-specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The National Institute on Deafness and Other Communication Disorders (NIDCD) has reported that in the United States, about 2 to 3 out of every 1000 children are born with hearing loss. Approximately 15% of adults in the United States aged 18 and up report hearing problems. The increasing number of citizens reporting hearing complications and the presence of thriving diagnostic centers make North America the global leader in the hearing screening and diagnostic devices market. In Europe, the rising prevalence of inherited hearing disorders and presbycusis propels the market for hearing screening and diagnostic devices.

According to World Health Organization 2015 statistics, approximately one-third of people over the age of 65 in the Asia-Pacific region suffer from hearing loss. Poor health awareness in low-income families regarding cleaning the earwax has resulted in otitis media, causing trauma to the ear drums. The competitive market created by the domestic players steers the Asian Pacific market's growth.

Frequently Asked Question:

The market for Hearing Screening And Diagnostic Devices Market is expected to reach USD$ XX Bn in 2025.

The Hearing Screening And Diagnostic Devices Market is expected to see significant CAGR growth over the coming years, at 5.42%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Accent Hearing Pty. Ltd., GN Otometrics, Interacoustics A/S, IntriCon Corporation, MAICO Diagnostics GmbH, Nashua Hearing Group, Natus Medical Incorporated, Neurosoft. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Dec 2017
Category:  Medical Devices
Report ID:   58890
Report Format:   PDF
Pages:   120
Rating:    4.7 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support